$71 Million is the total value of CARNEGIE MELLON UNIVERSITY's 6 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | DUOLINGO INC | $52,816,330 | -15.9% | 369,500 | -16.1% | 74.35% | +77.2% | |
| IEMG | Sell | ISHARES INCcore msci emkt | $17,798,767 | -79.4% | 361,103 | -79.6% | 25.06% | -56.6% |
| VERA | VERA THERAPEUTICS INC.cl a | $257,763 | +106.8% | 16,060 | 0.0% | 0.36% | +337.3% | |
| NBSE | Sell | NEUBASE THERAPEUTICS INC. | $87,834 | -49.5% | 46,970 | -95.0% | 0.12% | +6.9% |
| Sell | PREDICTIVE ONCOLOGY INC. | $50,340 | -25.7% | 10,358 | -95.0% | 0.07% | +57.8% | |
| IHT | INNSUITES HOSPITALITY TRUSTsh ben int | $23,900 | +74.5% | 10,000 | 0.0% | 0.03% | +277.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-01
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES INC | 8 | Q3 2023 | 79.8% |
| DUOLINGO INC | 8 | Q3 2023 | 77.3% |
| NEUBASE THERAPEUTICS INC. | 8 | Q3 2023 | 1.1% |
| VERA THERAPEUTICS INC. | 8 | Q3 2023 | 0.4% |
| PREDICTIVE ONCOLOGY INC. | 8 | Q3 2023 | 0.1% |
| INNSUITES HOSPITALITY TRUST | 8 | Q3 2023 | 0.0% |
| CARMELL THERAPEUTICS CORP | 1 | Q3 2023 | 0.5% |
View CARNEGIE MELLON UNIVERSITY's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NeuBase Therapeutics, Inc. | July 22, 2019 | 939,412 | 5.5% |
View CARNEGIE MELLON UNIVERSITY's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| 13F-HR | 2024-02-02 |
| 13F-HR | 2023-11-01 |
| 13F-HR | 2023-08-01 |
| 13F-HR | 2023-05-03 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-11 |
View CARNEGIE MELLON UNIVERSITY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.